Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 4c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $439.67 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• TOYO Co., Ltd (TOYO) Misses Q2 EPS by 24c
• Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance